UNASSIGNED:环介导的等温扩增(LAMP)是一种新颖的核酸扩增方法,仅使用一种类型的酶即可以高特异性扩增DNA,在等温条件下的效率和速度。复杂感染检测芯片(CCID)基于LAMP。本研究将CCID转化为临床应用,评价其对肺炎的诊断价值。
UNASSIGNED:从2021年1月1日至7月23日,前瞻性纳入了81例老年肺炎患者,收集了57例痰液/气道分泌物和35例支气管肺泡灌洗液样本,并通过CCID和常规微生物测试(CMT)进行了分析。样本被收集,运输,监控,并由多学科团队使用样品管理信息系统进行管理。
未授权:CCID周转时间为50分钟,检测限为500拷贝/反应。使用CCID的阳性样本百分比明显高于CMT,特别是肺炎克雷伯菌(比值比[OR],9.0;95%置信区间[CI],1.1-70.5;p<0.05),粪肠球菌(OR,∞;p<0.01),嗜麦芽窄食单胞菌(或,∞;p<0.01),真菌(或,26.0;95%CI,3.6-190.0;p<0.01),和病毒(仅CCID;p<0.01)。此外,在使用抗生素超过3天的患者中,使用CCID的阳性结果百分比明显高于CMT(91.9%vs.64.9%;p<0.01)。分析临床影响,55例(59.8%)受益于CCID。
UNASSIGNED:CCID可以快速准确地检测老年患者的肺炎。此外,该技术受先前抗生素治疗的影响较小,可以改善患者护理。
UNASSIGNED: Loop-mediated isothermal amplification (LAMP) is a novel nucleic acid amplification method using only one type of enzyme that can amplify DNA with high specificity, efficiency and rapidity under isothermal conditions. Chips for Complicated Infection Detection (CCID) is based on LAMP. This
study translate CCID into clinical application and evaluate its diagnostic value for pneumonia.
UNASSIGNED: Eighty one older patients with pneumonia were prospectively enrolled from January 1 to July 23, 2021, and 57 sputum/airway secretion and 35 bronchoalveolar lavage fluid samples were collected and analyzed by CCID and conventional microbiological tests (CMTs). Samples were collected, transported, monitored, and managed by a multidisciplinary team using a sample management information system.
UNASSIGNED: CCID turnaround time was 50 min, and the detection limit was 500 copies/reaction. The percentage of positive samples was significantly higher using CCID than CMTs, especially for Klebsiella pneumoniae (odds ratio [OR], 9.0; 95% confidence interval [CI], 1.1-70.5; p < 0.05), Enterococcus faecalis (OR, ∞; p < 0.01), Stenotrophomonas maltophilia (OR, ∞; p < 0.01), fungi (OR, 26.0; 95% CI, 3.6-190.0; p < 0.01), and viruses (CCID only; p < 0.01). In addition, the percentage of positive results was significantly higher using CCID than CMTs in patients who used antibiotics for more than 3 days (91.9% vs. 64.9%; p < 0.01). Analyzing clinical impact, 55 cases (59.8%) benefited from CCID.
UNASSIGNED: CCID allows the rapid and accurate detection of pneumonia in older patients. Moreover, this technique is less affected by previous antibiotic treatment and can improve patient care.